Princess Margaret

Toronto, Ontario M5T 2M9

1 studies enrolling now · 7 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Graft Versus Host Disease, Endometrial Cancer, Hematologic Malignancy, High Grade B-cell Lymphoma (HGBCL), Primary Mediastinal B-cell Lymphoma (PMBCL), Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B-Cell Lymphoma, Solid Malignancy, Stage I Multiple Myeloma, Stage II Multiple Myeloma

Studies at this site

• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma — Completed
• A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies — Enrolling by invitation
• Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma — Completed
• Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) — Stopped early
• Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML) — Stopped early
• Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD) — Stopped early